Ignite Creation Date:
2024-05-05 @ 5:29 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00466960
Status:
COMPLETED
Last Update Posted:
2017-08-28
First Post:
2007-04-25
Brief Title:
Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer Fallopian Tube Cancer or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy
Sponsor:
University of Washington
Organization:
University of Washington
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IV Ovarian Epithelial Cancer |
| Brenner Tumor |
| Fallopian Tube Cancer |
| Ovarian Clear Cell Cystadenocarcinoma |
| Ovarian Endometrioid Adenocarcinoma |
| Ovarian Mixed Epithelial Carcinoma |
| Ovarian Mucinous Cystadenocarcinoma |
| Ovarian Serous Cystadenocarcinoma |
| Ovarian Undifferentiated Adenocarcinoma |
| Peritoneal Cavity Cancer |
| Recurrent Ovarian Epithelial Cancer |
| Stage III Ovarian Epithelial Cancer |
Keywords: